Bridging the Gap: A High-Acuity Shadowing and Mentorship Experience for Medical-Surgical Nurses
June 10, 2026openalex
Back to Roadmap
RoadblockMental HealthPartial
Treatment-resistant depression
Approximately 30% of patients with major depressive disorder do not respond to two or more adequate antidepressant trials, qualifying as treatment-resistant depression (TRD). Current interventions such as esketamine, ECT, and deep brain stimulation show partial efficacy but lack predictive biomarkers for patient selection. Understanding why standard monoaminergic treatments fail and identifying alternative neurobiological targets (glutamatergic, GABAergic, neuroinflammatory pathways) remains a critical unsolved problem.
Recent papers / Mental Health
Modeling thyroid hormone-mediated neurodevelopment:Insights from human induced pluripotent stem cells
June 10, 2026openalex
Het onthullen van de immunogenetica van multiple sclerose - Inzichten uit meerlagige single-cellbenaderingen
June 10, 2026openalex
AI in Teaching & Learning -- Prospects and Pitfalls
June 10, 2026openalex
Seeing is Deceiving: Systematic Vulnerability Analysis of LiDAR-Based Autonomous Driving to Mirror-Induced Perception Failures
June 10, 2026openalex
The Sign-Tracker/Goal-Tracker Paradigm as a Behavioral Model for Exploring Addiction Vulnerability: A Translational Perspective
June 10, 2026openalex